ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Clinical Impact of Pre-Transplant Serum 25-Hydroxyvitamin D Levels on the Post-Transplant Immunologic and Non-Immunologic Outcomes in Kidney Transplant Recipients.

    T. Ban,1,2 J. Kim,1,2 Y. Lee,1 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim,1,2 B. Chung.1,2

    1Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea; 2Transplant Research Center, Seoul St. Mary's Hospital, Seoul, Korea.

    Background: The aim of this study is to investigate the clinical significance of pre-transplant serum 25-hydroxyvitamin D (25(OH)D) levels in regard to post-transplant clinical outcome…
  • 2016 American Transplant Congress

    Analysis of T Cell Receptor Repertoire in Routine Renal Allograft Biopsy.

    R. Reindl-Schwaighofer,1 J. Weinberger,1 R. Jimenez-Heredia,1 J. Sunzenauer,1 S. Schaller,2 S. Winkler,2 R. Oberbauer.1

    1Department of Nephrology, Medical University of Vienna, Vienna, Austria; 2Bioinformatics Research Group, University of Applied Sciences Upper Austria, Hagenberg, Austria.

    Introduction: Diversity and clonality of the T cell repertoire of circulating and tissue-resident T-cells can be assessed by sequencing of recombined T cell receptor (TCR)…
  • 2016 American Transplant Congress

    Impaired Outcome of Kidney Transplants from Donors with Acute Kidney Injury.

    K. Schuette-Nuetgen,1 G. Thölking,1 H. Pavenstädt,1 S. Ehlert,1 B. Suwelack,1 D. Palmes,2 R. Bahde,2 S. Reuter.1

    1Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, Muenster, Germany; 2Department of General and Visceral Surgery, University Hospital of Muenster, Muenster, Germany.

    Given the gap between patients in need of a kidney transplantation and organs available, transplantation centers increasingly accept lower quality organs, e.g. from donors with…
  • 2016 American Transplant Congress

    Clinical Outcome on Kidney Retransplantation in Comparison with First Kidney Transplantation in Korea – Nationwide Cohort Study.

    J. Kim,1,2 T. Ban,1,2 B. Jung,1,2 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim.1,2

    1Transplantation Research Center, Seoul St. Mary's Hospital, Seoul, Republic of Korea; 2Internal Medicine, Seoul St. Mary's Hospital, Seoul, Republic of Korea.

    Due to the limitation of the survival of kidney allograft, increasing number of patients need to take re-transplantation (re-KT) after the first allograft failure. In…
  • 2016 American Transplant Congress

    Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.

    R. Evans,1 N. Neville,2 A. Fugit,3 R. Gedaly,1 T. Clifford.1

    1University of Kentucky Healthcare, Lexington, KY; 2University of Kentucky College of Pharmacy, Lexington, KY; 3Vidant Medical Center, Greenville, NC.

    Purpose: To determine the impact and correlation of pre-transplant chronic opiate use with post-transplant chronic opiate use, resource utilization, and patient survival in addition to…
  • 2016 American Transplant Congress

    Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.

    G. Malat,4 S. DiLollo,1 D. Lee,2 A. Sharma,3 T. Bias,2 M. Harhay,3 K. Ranganna,3 A. Doyle.3

    1Colonia Natural Pharmacy, Colonia; 2Medicine/Surgery, Drexel University, Philadelphia.

    Introduction We describe the implementation of a vaccine initiative in an ambulatory transplant setting.Methods In 2014, Hahnemann University Hospital (HUH) and Colonia Natural Pharmacy transplant…
  • 2016 American Transplant Congress

    High Tacrolimus Dose Requirements at Month 6 Are Associated with Inferior Graft Function in Renal Transplant Patients.

    O. Rissling, S. Brakemeier, L. Lehner, F. Halleck, O. Staeck, D. Schmidt, K. Budde.

    Department of Nephrology, Charité Universitaetsmedizin, Berlin, Germany.

    Introduction: Tacrolimus (Tac), the mainstay of immunosuppression in renal transplant (tx) patients (pts) is known for drug induced nephrotoxicity, which may limit graft survival.Methods: In…
  • 2016 American Transplant Congress

    High KDPI Is a Predictor of Acute Rejection in Delayed Graft Function.

    B. Muth,1 J. Turk,1 S. Parajuli,1 D. Mandelbrot,1 M. Mohamed,1 R. Redfield,2 D. Kaufman,2 A. Djamali.1,2

    1Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI; 2Department of Surgery, Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, WI.

    The kidney donor profile index (KDPI) is a prognostic measure for graft function and survival. It is unclear whether it predicts acute rejection in patients…
  • 2016 American Transplant Congress

    Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?

    D. Khadzhynov, F. Halleck, L. Lehner, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.

    Nephrology, Charite Universitaetsmedizin, Berlin, Germany.

    Background: Coronary artery disease is a frequent comorbidity among transplant candidates. Limited data exist on the long-term outcomes of kidney transplant recipients (KTR) with pre-existing…
  • 2016 American Transplant Congress

    Patients Treated with Belatacept Show Low Levels of APRIL and HLA Antibodies.

    M. Rial,1 N. Ambrosi,2 F. Caro,2 D. Curcio,1 J. Salaberry,2 O. Guardia,1 A. Dotta,1 D. Guerrieri,2 K. Padros,3 E. Chuluyan,2 D. Casadei.

    1Instituto de Nefrología, Nephrology, Buenos Aires, Argentina; 2CEFYBO, Facultad de Medicina, UBA-CONICET, Buenos Aires, Argentina; 3PRICAI, Fundación Favaloro, Buenos Aires, Argentina.

    Belatacept, a fusión protein that blocks the B7-CD28 costimulation pathway, decreases the level of antibodies in non-human primates and murine models but, few studies have…
  • « Previous Page
  • 1
  • …
  • 425
  • 426
  • 427
  • 428
  • 429
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences